Protein (2)
Launched (2)
Human (2)
His Tag (1)His Tag & Avi Tag (1)
Unconjugated (1)Biotin-labeled (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
HLG-H52E9 | HEK293 | Human HLA-G&B2M&Peptide (RIIPRHLQL) Tetramer Protein (MALS verified) | |||||
HLM-H82E4 | HEK293 | Biotinylated Human HLA-G&B2M&Peptide (RIIPRHLQL) Complex Protein (Monomer, MALS verified) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Osugacestat | AL-101(BMS); BMS-906024 | Phase 2 Clinical | Bristol-Myers Squibb Company, Glaxosmithkline Plc | Triple Negative Breast Neoplasms; Neoplasms; Carcinoma, Adenoid Cystic; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Details |




